🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

525 results for “Teva” Clear

  1. Bronchodilator

    Teva Pharma GmbH

    Asthma

    phase 2 small molecule completed

    1 trial

  2. Budenofalk 3mg magensaftresistente Hartkapseln, ALIMTA 100 mg powder for concentrate for solution for infusion, KEYTRUDA 25 mg/mL concentrate for solution for infusion., CISPLATINE ACCORD 1 mg/ml, solution à diluer pour perfusion, Carboplatin-GRY® 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Cisplatin NeoCorp 1 mg/ml - Konzentrat zur Herstellung einer Infusionslösung, Pemetrexed Accord 25 mg/ml concentrate for solution for infusion, Cisplatin Teva® 1 mg/ml Konzentrat zur Herstellung einer Infu

    Roche Registration Limited

    Untreated Advanced or Metastatic Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  3. CAMPTO 20 mg/mL concentrate for solution for infusion, Futibatinib, Leucovorin-Teva 10 mg/ml Concentrate for Solution for Infusion, FLUOROURACIL, CISPLATIN, OXALIPLATIN, KEYTRUDA 25 mg/mL concentrate for solution for infusion

    Taiho Pharma Netherlands B.V.

    Solid Tumors

    phase 2 small molecule active

    1 trial

  4. CEP-18770

    Teva Pharma GmbH

    Multiple Myeloma

    phase 2 small molecule terminated

    2 trials

  5. CEP-37247

    Teva Pharma GmbH

    Sciatica

    phase 2 small molecule completed

    1 trial

  6. CEP-701

    Teva Pharma GmbH

    Prostate Cancer

    phase 2 small molecule completed

    1 trial

  7. CEP-701

    Teva Pharma GmbH

    Acute Myeloid Leukemia

    phase 2 small molecule completed

    1 trial

  8. CEP-701 20mg

    Teva Pharma GmbH

    Psoriasis

    phase 2 small molecule completed

    1 trial

  9. CEP-701 60mg

    Teva Pharma GmbH

    Leukemia, Myeloid

    phase 2 small molecule completed

    1 trial

  10. CEP-9722

    Teva Pharma GmbH

    Solid Tumors

    phase 2 small molecule terminated

    1 trial

  11. CT-011

    Teva Pharma GmbH

    Primary Hepatocellular Carcinoma

    phase 2 small molecule terminated

    1 trial

  12. CT-011

    Teva Pharma GmbH

    Chronic Hepatitis C

    phase 2 small molecule terminated

    1 trial

  13. Calcio levofolinato Teva Generics 175 mg polvere per soluzione per infusione, BEVACIZUMAB , ZALTRAP 25 mg/ml concentrate for solution for infusion, Oxaliplatin 5 mg/ml concentrate for solution for infusion, Stivarga 40 mg film-coated tablets, FLUOROURACIL , FLUOROURACIL , Irinotecan Accord 20 mg/ml concentrato per soluzione per infusione, CAPECITABINE

    Fondazione Telethon ETS

    Patients with metastatic colorectal cancer (mCRC) RAS-mutant

    phase 2 small molecule active

    1 trial

  14. Carboplatin

    Teva Pharma GmbH

    Prostatic Neoplasm

    phase 2 small molecule terminated

    1 trial

  15. Chlorambucil

    Teva Pharma GmbH

    Chronic Lymphocytic Leukemia

    phase 2 small molecule terminated

    1 trial

  16. Cyproterone acetate 5

    Teva Pharma GmbH

    Prostate Cancer

    phase 2 small molecule completed

    1 trial

  17. Cytarabine

    Teva Pharma GmbH

    Acute Myeloid Leukemia

    phase 2 small molecule terminated

    1 trial

  18. DR-1031

    Teva Pharma GmbH

    Breakthrough Bleeding

    phase 2 small molecule completed

    1 trial

  19. DR-2001a

    Teva Pharma GmbH

    Endometriosis

    phase 2 small molecule completed

    1 trial

  20. DR-2021a

    Teva Pharma GmbH

    Amenorrhea

    phase 2 small molecule completed

    1 trial

  21. DR-3001a

    Teva Pharma GmbH

    Urinary Incontinence

    phase 2 small molecule completed

    1 trial

  22. Dasatinib/Teva 50 mg επικαλυμμένα με λεπτό υμένιο δισκία, Maltodextrine powder, SPRYCEL 20 mg film-coated tablets

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Human immunodeficiency virus

    phase 2 small molecule active

    1 trial

  23. Decitabine

    Teva Pharma GmbH

    Acute Myeloid Leukemia

    phase 2 small molecule completed

    1 trial

  24. Delayed Release 6 mercaptopurine

    Teva Pharma GmbH

    Crohn's Disease

    phase 2 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources